Contact Us
 • 
Home
Search 

Clinical Trials > SelPac  

  • Information
  • Map of Sites
SelPac   

Title

A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or interrupted Selumetinib in combination with weekly Paclitaxel in Metastatic Uveal Melanoma.


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Recruitment
II Open University of Liverpool 32

Trial Start Date

26/08/2015


Trial Coordinator

Louise Handley


Trial Coordinator Email Address

Louise.Handley@Liverpool.Ac.UK


Trial Coordinator Contact No

0151 794 8935


Interactive Map  

To find out more information about a hospital within your area click on the pin.